Drug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23

Section 1.1

Executive officer and interchangeability

Cite as Drug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23, s. 1.1 · current to November 11, 2026 · consolidated from June 3, 2016 · read from e-Laws on November 16, 2026

The text

(1) The executive officer may designate a product as being interchangeable with another product by designating it as such in the Formulary. 2006, c. 14, s. 2. (2) A product becomes interchangeable with another product on the effective date of its being designated as interchangeable with that product, and ceases to be interchangeable with that product on the effective date of the removal of its interchangeability designation by the executive officer. 2006, c. 14, s. 2. (3) The executive officer may designate a product as being interchangeable with another product if it is in the public interest to do so, but shall not do so if, (a) it does not contain a drug or drugs in the same amounts of the same or similar active ingredients in the same or similar dosage form as the other product; or (b) the prescribed conditions under clause 14 (1) (a) have not been met. 2006, c. 14, s. 2. (4) In clause (3) (a), “similar active ingredients” means different salts, esters, complexes or solvates of the same therapeutic moiety. 2006, c. 14, s. 2. (5) The executive officer may remove a product’s interchangeability designation, (a) where authorized to do so under subsection 12.1 (8); (b) if one of the conditions prescribed under clause 14 (1) (b) has been breached; or (c) in any case, if he or she considers it advisable in the public interest to do so. 2006, c. 14, s. 2. (6) Any modification of a designation takes place on the effective date of its being designated in the Formulary as a modification. 2006, c. 14, s. 2. (7) The Statutory Powers Procedure Act does not apply to anything done by the executive officer under this Act. 2006, c. 14, s. 2. (8) A product that was interchangeable with another product immediately before October 1, 2006 continues to be interchangeable with that product until its interchangeability designation is removed by the executive officer. 2006, c. 14, s. 2.
Read the Drug Interchangeability and Dispensing Fee Act on e-Laws ↗